TY - JOUR
T1 - Mapping subnational HIV mortality in six Latin American countries with incomplete vital registration systems
AU - Local Burden of Disease HIV Collaborators
AU - Cork, Michael A.
AU - Henry, Nathaniel J.
AU - Watson, Stefanie
AU - Croneberger, Andrew J.
AU - Baumann, Mathew
AU - Letourneau, Ian D.
AU - Yang, Mingyou
AU - Serfes, Audrey L.
AU - Abbas, Jaffar
AU - Abbasi, Nooshin
AU - Abbastabar, Hedayat
AU - Abreu, Lucas G.
AU - Abu-Gharbieh, Eman
AU - Achappa, Basavaprabhu
AU - Adabi, Maryam
AU - Adal, Tadele G.
AU - Adegbosin, Adeyinka E.
AU - Adekanmbi, Victor
AU - Adetokunboh, Olatunji O.
AU - Agudelo-Botero, Marcela
AU - Ahinkorah, Bright O.
AU - Ahmadi, Keivan
AU - Ahmed, Muktar B.
AU - Alhassan, Robert K.
AU - Alipour, Vahid
AU - Almasi-Hashiani, Amir
AU - Alvis-Guzman, Nelson
AU - Ancuceanu, Robert
AU - Andrei, Tudorel
AU - Anvari, Davood
AU - Aqeel, Muhammad
AU - Arabloo, Jalal
AU - Aremu, Olatunde
AU - Asaad, Malke
AU - Atnafu, Desta D.
AU - Atreya, Alok
AU - Paulina Ayala Quintanilla, Beatriz
AU - Azari, Samad
AU - B B, Darshan
AU - Baig, Atif A.
AU - Banach, Maciej
AU - Bante, Simachew A.
AU - Barboza, Miguel A.
AU - Basu, Sanjay
AU - Bedi, Neeraj
AU - F Bejarano Ramirez, Diana
AU - Bensenor, Isabela M.
AU - Beyene, Fentahun Y.
AU - Bezabih, Yihienew M.
AU - Iqbal, Usman
N1 - Funding Information:
This work was primarily supported by grant OPP1132415 from the Bill & Melinda Gates Foundation. The funder of the study had no role in study design, data collection, data analysis, data interpretation, writing of the report, or decision to publish. The corresponding authors had full access to all the data in the study and had final responsibility for the decision to submit for publication.
Funding Information:
Dr. Singh reports personal fees from Crealta/Horizon, Medisys, Fidia, UBM LLC, Trio health, Medscape, WebMD, Clinical Care options, Clearview healthcare partners, Putnam associates, Focus forward, Navigant consulting, Spherix, Practice Point communications, the National Institutes of Health and the American College of Rheumatology, personal fees from Simply Speaking, other from Amarin, Viking, Moderana and Vaxart pharmaceuticals, non-financial support from FDA Arthritis Advisory Committee, non-financial support from Steering committee of OMERACT, an international organization that develops measures for clinical trials and receives arm’s length funding from 12 pharmaceutical companies, non-financial support from Veterans Affairs Rheumatology Field Advisory Committee, non-financial support from Editor and the Director of the UAB Cochrane Musculoskeletal Group Satellite Center on Network Meta-analysis, outside the submitted work. Dr. Krishan reports grants from UGC Centre of Advanced Study, CAS II, awarded to the Department of Anthropology, Panjab University, Chandigarh, India, outside the submitted work. Prof. Postma reports grants and personal fees from various pharmaceutical industries, all outside the submitted work. Prof Postma holds stocks in Ingress Health and Pharmacoeconomics Advice Groningen (PAG Ltd) and is advisor to Asc Academics, all pharmacoeconomic consultancy companies. Dr. Ancuceanu reports he received consultancy and speakers’ fees from various pharmaceutical companies. Walter Mendoza is a Program Analyst in Population and Development at the United Nations Population Fund-UNFPA Country Office in Peru, an institution which does not necessarily endorse this study. Dr. Pandi-Perumal reports a non-financial relationship with Somnogen Canada Inc. and occasional royalities from publishing houses, outside the submitted work.
Publisher Copyright:
© 2021, The Author(s).
PY - 2021/12
Y1 - 2021/12
N2 - Background: Human immunodeficiency virus (HIV) remains a public health priority in Latin America. While the burden of HIV is historically concentrated in urban areas and high-risk groups, subnational estimates that cover multiple countries and years are missing. This paucity is partially due to incomplete vital registration (VR) systems and statistical challenges related to estimating mortality rates in areas with low numbers of HIV deaths. In this analysis, we address this gap and provide novel estimates of the HIV mortality rate and the number of HIV deaths by age group, sex, and municipality in Brazil, Colombia, Costa Rica, Ecuador, Guatemala, and Mexico. Methods: We performed an ecological study using VR data ranging from 2000 to 2017, dependent on individual country data availability. We modeled HIV mortality using a Bayesian spatially explicit mixed-effects regression model that incorporates prior information on VR completeness. We calibrated our results to the Global Burden of Disease Study 2017. Results: All countries displayed over a 40-fold difference in HIV mortality between municipalities with the highest and lowest age-standardized HIV mortality rate in the last year of study for men, and over a 20-fold difference for women. Despite decreases in national HIV mortality in all countries—apart from Ecuador—across the period of study, we found broad variation in relative changes in HIV mortality at the municipality level and increasing relative inequality over time in all countries. In all six countries included in this analysis, 50% or more HIV deaths were concentrated in fewer than 10% of municipalities in the latest year of study. In addition, national age patterns reflected shifts in mortality to older age groups—the median age group among decedents ranged from 30 to 45 years of age at the municipality level in Brazil, Colombia, and Mexico in 2017. Conclusions: Our subnational estimates of HIV mortality revealed significant spatial variation and diverging local trends in HIV mortality over time and by age. This analysis provides a framework for incorporating data and uncertainty from incomplete VR systems and can help guide more geographically precise public health intervention to support HIV-related care and reduce HIV-related deaths.
AB - Background: Human immunodeficiency virus (HIV) remains a public health priority in Latin America. While the burden of HIV is historically concentrated in urban areas and high-risk groups, subnational estimates that cover multiple countries and years are missing. This paucity is partially due to incomplete vital registration (VR) systems and statistical challenges related to estimating mortality rates in areas with low numbers of HIV deaths. In this analysis, we address this gap and provide novel estimates of the HIV mortality rate and the number of HIV deaths by age group, sex, and municipality in Brazil, Colombia, Costa Rica, Ecuador, Guatemala, and Mexico. Methods: We performed an ecological study using VR data ranging from 2000 to 2017, dependent on individual country data availability. We modeled HIV mortality using a Bayesian spatially explicit mixed-effects regression model that incorporates prior information on VR completeness. We calibrated our results to the Global Burden of Disease Study 2017. Results: All countries displayed over a 40-fold difference in HIV mortality between municipalities with the highest and lowest age-standardized HIV mortality rate in the last year of study for men, and over a 20-fold difference for women. Despite decreases in national HIV mortality in all countries—apart from Ecuador—across the period of study, we found broad variation in relative changes in HIV mortality at the municipality level and increasing relative inequality over time in all countries. In all six countries included in this analysis, 50% or more HIV deaths were concentrated in fewer than 10% of municipalities in the latest year of study. In addition, national age patterns reflected shifts in mortality to older age groups—the median age group among decedents ranged from 30 to 45 years of age at the municipality level in Brazil, Colombia, and Mexico in 2017. Conclusions: Our subnational estimates of HIV mortality revealed significant spatial variation and diverging local trends in HIV mortality over time and by age. This analysis provides a framework for incorporating data and uncertainty from incomplete VR systems and can help guide more geographically precise public health intervention to support HIV-related care and reduce HIV-related deaths.
KW - HIV mortality
KW - HIV/AIDS
KW - Latin America
KW - Mapping
KW - Small area estimation
KW - Spatial statistics
KW - Vital registration
UR - http://www.scopus.com/inward/record.url?scp=85102170519&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=85102170519&partnerID=8YFLogxK
U2 - 10.1186/s12916-020-01876-4
DO - 10.1186/s12916-020-01876-4
M3 - Article
C2 - 33413343
AN - SCOPUS:85102170519
SN - 1741-7015
VL - 19
JO - BMC Medicine
JF - BMC Medicine
IS - 1
M1 - 4
ER -